Tofenacin
Tofenacin[edit]

Tofenacin is a tricyclic antidepressant (TCA) that was developed in the 1960s. It is primarily used in the treatment of depression and has been studied for its effects on various neurotransmitter systems in the brain.
Pharmacology[edit]
Tofenacin works by inhibiting the reuptake of norepinephrine and serotonin, two key neurotransmitters involved in mood regulation. This action increases the concentration of these neurotransmitters in the synaptic cleft, thereby enhancing neurotransmission and improving mood in patients with depression.
Chemical Properties[edit]
Tofenacin is a member of the tricyclic antidepressant class, characterized by its three-ring chemical structure. The chemical structure of Tofenacin is depicted in the image to the right. This structure is crucial for its ability to interact with neurotransmitter transporters in the brain.
Clinical Use[edit]
Tofenacin is prescribed for the treatment of major depressive disorder. It is typically administered orally and dosage is adjusted based on the patient's response and tolerance to the medication. Like other TCAs, Tofenacin may take several weeks to exhibit its full therapeutic effects.
Side Effects[edit]
Common side effects of Tofenacin include dry mouth, constipation, urinary retention, and blurred vision. These effects are due to its anticholinergic properties. Patients may also experience drowsiness, weight gain, and orthostatic hypotension.
Mechanism of Action[edit]
Tofenacin's primary mechanism of action is the inhibition of the reuptake of norepinephrine and serotonin. By blocking the transporters responsible for the reuptake of these neurotransmitters, Tofenacin increases their availability in the synaptic cleft, which is thought to contribute to its antidepressant effects.
History[edit]
Tofenacin was developed in the 1960s during a period of extensive research into tricyclic antidepressants. It was one of several compounds synthesized to improve the efficacy and reduce the side effects associated with earlier antidepressants.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian